HMOX1 and Parkinson disease: Pharmacological induction of HO-1 by administration of bioactive compounds can exert therapeutic effects against 6-OHDA (Table 7), MPP+ (Table 8), MPTP (Table 9), paraquat (Table 10), and rotenone-induced (Table 11) neurotoxicity in vitro or in vivo PD models.